Ferdinando Maria Milazzo

912 total citations
30 papers, 692 citations indexed

About

Ferdinando Maria Milazzo is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ferdinando Maria Milazzo has authored 30 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Ferdinando Maria Milazzo's work include Histone Deacetylase Inhibitors Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Ferdinando Maria Milazzo is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Ferdinando Maria Milazzo collaborates with scholars based in Italy, Switzerland and France. Ferdinando Maria Milazzo's co-authors include Giuseppe Giannini, Silvia Rivara, Loredana Vesci, Marco Mor, Giuseppe Roscilli, Marcella Barbarino, Claudio Pisano, Gianfranco Battistuzzi, Daniele Pala and Mario B. Guglielmi and has published in prestigious journals such as Cancer Research, Chemical Communications and Clinical Cancer Research.

In The Last Decade

Ferdinando Maria Milazzo

30 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferdinando Maria Milazzo Italy 15 448 218 199 163 50 30 692
Iana M. Serafimova United States 7 665 1.5× 346 1.6× 243 1.2× 136 0.8× 61 1.2× 8 958
Laurie A. LeBrun United States 16 642 1.4× 99 0.5× 153 0.8× 160 1.0× 34 0.7× 23 888
Jaimeen D. Majmudar United States 15 567 1.3× 163 0.7× 113 0.6× 142 0.9× 32 0.6× 24 813
W.C. Voegtli United States 17 724 1.6× 182 0.8× 113 0.6× 143 0.9× 41 0.8× 25 1.0k
Eileen S. Walsh United States 17 508 1.1× 133 0.6× 164 0.8× 208 1.3× 59 1.2× 20 844
Yangping Wu China 14 509 1.1× 212 1.0× 152 0.8× 244 1.5× 64 1.3× 22 933
Christopher J. Stubbs United Kingdom 15 509 1.1× 67 0.3× 115 0.6× 158 1.0× 54 1.1× 33 785
Claire Coderch Spain 15 322 0.7× 112 0.5× 127 0.6× 179 1.1× 15 0.3× 28 520
Carrow I. Wells United States 18 566 1.3× 132 0.6× 160 0.8× 187 1.1× 16 0.3× 46 843
S.L. Gande Germany 15 475 1.1× 74 0.3× 133 0.7× 130 0.8× 18 0.4× 30 718

Countries citing papers authored by Ferdinando Maria Milazzo

Since Specialization
Citations

This map shows the geographic impact of Ferdinando Maria Milazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinando Maria Milazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinando Maria Milazzo more than expected).

Fields of papers citing papers by Ferdinando Maria Milazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdinando Maria Milazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinando Maria Milazzo. The network helps show where Ferdinando Maria Milazzo may publish in the future.

Co-authorship network of co-authors of Ferdinando Maria Milazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdinando Maria Milazzo. A scholar is included among the top collaborators of Ferdinando Maria Milazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdinando Maria Milazzo. Ferdinando Maria Milazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giannini, Giuseppe, Sara Soldi, Marina Elli, et al.. (2025). A mixture of postbiotics/tyndallized probiotics reduces trimethylamine (TMA) in trimethylaminuria models: Evidence from in vitro and in vivo studies. Frontiers in Pharmacology. 16. 1591825–1591825. 1 indexed citations
2.
Cini, Elena, Elena Petricci, Maurizio Taddei, et al.. (2021). Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibition. Chemical Communications. 57(7). 867–870. 9 indexed citations
3.
Pala, Daniele, Laura Scalvini, Alessio Lodola, et al.. (2020). New classes of potent heparanase inhibitors from ligand-based virtual screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1685–1696. 11 indexed citations
4.
Milazzo, Ferdinando Maria, Loredana Vesci, Anna Maria Anastasi, et al.. (2020). ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1. Frontiers in Oncology. 9. 1534–1534. 13 indexed citations
5.
Vlodavsky, Israël, Uri Barash, Giuseppe Roscilli, et al.. (2019). Novel N-acetyl-Glycol-split heparin biotin-conjugates endowed with anti-heparanase activity. European Journal of Medicinal Chemistry. 186. 111831–111831. 12 indexed citations
6.
Giannini, Giuseppe, Ferdinando Maria Milazzo, Gianfranco Battistuzzi, et al.. (2019). Synthesis and preliminary in vitro evaluation of DOTA-Tenatumomab conjugates for theranostic applications in tenascin expressing tumors. Bioorganic & Medicinal Chemistry. 27(15). 3248–3253. 9 indexed citations
7.
Madia, Valentina Noemi, Antonella Messore, Luca Pescatori, et al.. (2018). Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity. Journal of Medicinal Chemistry. 61(15). 6918–6936. 28 indexed citations
8.
Cini, Elena, Elena Petricci, Maurizio Taddei, et al.. (2018). Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation. Chemical Science. 9(31). 6490–6496. 22 indexed citations
9.
Vesci, Loredana, Ferdinando Maria Milazzo, Maria Antonietta Stasi, et al.. (2018). Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 157. 368–379. 15 indexed citations
10.
Pala, Daniele, Silvia Rivara, Marco Mor, et al.. (2016). Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase. Glycobiology. 26(6). 640–654. 61 indexed citations
11.
Rivara, Silvia, Ferdinando Maria Milazzo, & Giuseppe Giannini. (2016). Heparanase: A Rainbow Pharmacological Target Associated to Multiple Pathologies Including Rare Diseases. Future Medicinal Chemistry. 8(6). 647–680. 139 indexed citations
12.
Taddei, Maurizio, Serena Ferrini, Massimo Corsi, et al.. (2014). Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold. Journal of Medicinal Chemistry. 57(6). 2258–2274. 63 indexed citations
13.
Santis, Rita De, Anna Maria Anastasi, Barbara Leoni, et al.. (2014). Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab. Oncotarget. 5(19). 9239–9255. 11 indexed citations
14.
Cincinelli, Raffaella, Loana Musso, Lucio Merlini, et al.. (2013). 7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors. Bioorganic & Medicinal Chemistry. 22(3). 1089–1103. 46 indexed citations
15.
Giannini, Giuseppe, Gianfranco Battistuzzi, Loredana Vesci, et al.. (2013). Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold. Bioorganic & Medicinal Chemistry Letters. 24(2). 462–466. 31 indexed citations
16.
Bargiotti, Alberto, Loana Musso, Sabrina Dallavalle, et al.. (2012). Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors. European Journal of Medicinal Chemistry. 53. 64–75. 32 indexed citations
17.
Pisano, Claudio, Loredana Vesci, Ferdinando Maria Milazzo, et al.. (2010). Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl- l -Carnitine. Clinical Cancer Research. 16(15). 3944–3953. 24 indexed citations
18.
19.
Perrone, Maria Grazia, Paola Vitale, Nicola Antonio Colabufo, et al.. (2007). Stereospecific synthesis and bio-activity of novel β3-adrenoceptor agonists and inverse agonists. Bioorganic & Medicinal Chemistry. 16(5). 2473–2488. 25 indexed citations
20.
Angelucci, Cristiana, et al.. (1996). Oncogene expression is modulated by recombinant human interferon-β in human breast-cancer cells. International Journal of Cancer. 67(3). 441–446. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iana M. Serafimova Breakdown of academic impact, for papers by Laurie A. LeBrun Breakdown of academic impact, for papers by Jaimeen D. Majmudar Breakdown of academic impact, for papers by W.C. Voegtli Breakdown of academic impact, for papers by Eileen S. Walsh Breakdown of academic impact, for papers by Yangping Wu Breakdown of academic impact, for papers by Christopher J. Stubbs Breakdown of academic impact, for papers by Claire Coderch Breakdown of academic impact, for papers by Carrow I. Wells Breakdown of academic impact, for papers by S.L. Gande
Rankless by CCL
2026